To Examine the Efficacy of Omalizumab in Patients with Chronic Idiopathic Urticaria
碩士 === 國立中正大學 === 生物醫學研究所 === 104 === Chronic Idiopathic urticaria (CIU), also known as chronic spontaneous urticaria (CSU), is defined by the presence of urticaria (hives), on most days of the week, for a period of six weeks or longer. About 40 percent of patients with CIU/CSU have accompanying epi...
Main Authors: | HSU, BAO-BAO, 許寶寶 |
---|---|
Other Authors: | HUANG, HSIEN-BIN |
Format: | Others |
Language: | en_US |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/41290179733353679401 |
Similar Items
-
Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
by: Che-Wen Yang, et al.
Published: (2017-12-01) -
Omalizumab in the treatment of chronic urticaria
by: Kiran Godse
Published: (2018-01-01) -
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
by: Diana C. Carrillo, et al.
Published: (2014-01-01) -
Omalizumab for chronic urticaria in Latin America
by: Paul Wilches, et al.
Published: (2016-01-01) -
Omalizumab for chronic urticaria in Latin America
by: Paul Wilches, et al.
Published: (2016-11-01)